The prevalence of illicit drug use in intensive cardiac care unit ICCU patients - Video
|
Overview
Illicit drug use is associated with a nearly nine-fold greater risk of death or life-threatening emergencies in intensive cardiac care unit (ICCU) patients, according to research presented at ESC Congress 2022.
The ADDICT-ICCU study assessed the prevalence of illicit drug use and the association with in-hospital major adverse events in consecutive patients admitted for acute cardiovascular events. From 7 to 22 April 2021, all consecutive patients admitted to ICCU in 39 centers throughout France provided a urine sample tested for illegal drugs.
A total of 1,499 patients were screened. Reasons for admission included myocardial infarction, acute heart failure, arrhythmias, myocarditis, and pulmonary embolism.10.7% had a positive test for at least one illicit drug.
Patients who used illicit drugs tended to be young:33% of patients under 40 years of age were users compared with just 6% of those aged 60 years or above.
During a median hospitalization of five days, 4.1% had a major adverse event. Illicit drug use was associated with an almost nine-fold odds of major adverse events after adjusting for comorbidities. After adjustment for age and sex, cannabis use was associated with a three-fold odds of major adverse events while cocaine was associated with a five-fold odds. Of those using drugs, 28% took more than one type of drug. Multiple drug use was associated with a higher incidence of major adverse events than single drug use.
Ref:
Dr. Theo Pezel et al, ESC Congress 2022.
Speakers
Isra Zaman
B.Sc Life Sciences, M.Sc Biotechnology, B.Ed
Isra Zaman is a Life Science graduate from Daulat Ram College, Delhi University, and a postgraduate in Biotechnology from Amity University. She has a flair for writing, and her roles at Medicaldialogues include that of a Sr. content writer and a medical correspondent. Her news pieces cover recent discoveries and updates from the health and medicine sector. She can be reached at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751
